Genetic test aims to improve breast cancer decisions for black and hispanic women
NCT ID NCT05755269
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether adding a polygenic risk score (a genetic test) to standard breast cancer risk tools helps African American and Hispanic women make better decisions about screening and prevention. Researchers enrolled 19 women at higher risk for breast cancer. The study was terminated early, so findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that personalized genetic risk information helps minority women choose better breast cancer screening and prevention.
- What could go wrong
- The study was terminated early with only 19 participants, so results are limited and may not apply broadly. It was a small, early-stage feasibility study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST ATYPICAL DUCTAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Phone-Based navigation could boost breast cancer detection in kenya
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a sticky film shield breast cancer patients from radiation burns in tropical heat?
- Can a simpler, cheaper method for marking breast tumors work as well as ultrasound?
- Could adding chemo help older breast cancer patients live longer? a major trial investigates.